News | December 28, 2023
Elpiscience and Astellas collaborate for novel bispecific macrophage engager
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
NEIAFMR to be developed as the national hub for folk medicine
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
US FDA approval based on NEURO-TTRansform Phase III results
World HRD Congress is a well-known international body of Management Studies
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Subscribe To Our Newsletter & Stay Updated
